We are live on !
Find out more
Bender Robert & Associates Portfolio holdings
AUM
$525M
Turnover
26.53%
1-Year Est. Return
38.43%
This Fund
S&P 500
This Quarter Est. Return
+9.61%
1 Year Est. Return
+38.43%
3 Year Est. Return
+145.82%
5 Year Est. Return
+189.35%
10 Year Est. Return
+1,046.87%
AUM
$525M
AUM Growth
+$43.4M
(+9%)
Cap. Flow
+$2.65M
Cap. Flow % of AUM
Cap. Flow %
0.5%
Top 10 Holdings %
Top 10 Hldgs %
71.92%
Holding
49
New
10
Increased
13
Reduced
19
Closed
3
Avg Time Held
1.5
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$12.5M |
| 2 |
UroGen Pharma
URGN
|
+$1.49M |
| 3 |
GE Vernova
GEV
|
+$652K |
| 4 |
Intuitive Surgical
ISRG
|
+$382K |
| 5 |
GE Aerospace
GE
|
+$348K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$5.93M |
| 2 |
Advanced Micro Devices
AMD
|
+$3.68M |
| 3 |
NVIDIA
NVDA
|
+$2.73M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.94M |
| 5 |
Broadcom
AVGO
|
+$235K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 51.17% |
| 2 | Consumer Discretionary | 15.54% |
| 3 | Healthcare | 14.98% |
| 4 | Communication Services | 12.92% |
| 5 | Industrials | 2.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Home Depot
HD
$328B
| $2.6M | 0.5% |
9,134
+345
| +4% | +$113K |
2024 Q3
8 quarters
|
|
|
27
UroGen Pharma
URGN
$1.64B
| $1.41M | 0.27% |
+34,701
| New | +$1.49M |
2026 Q3
0 quarters
|
|
28
Costco
COST
$441B
| $1.15M | 0.22% |
1,268
| – | – |
2024 Q3
8 quarters
|
|
29
AbbVie
ABBV
$514B
| $850K | 0.16% |
3,251
+858
| +36% | +$220K |
2024 Q3
8 quarters
|
|
30
Johnson & Johnson
JNJ
$662B
| $849K | 0.16% |
3,207
-17
| -0.5% | -$4.48K |
2024 Q3
8 quarters
|
|
31
JPMorgan Chase
JPM
$912B
| $814K | 0.16% |
2,462
-19
| -0.8% | -$6.65K |
2026 Q1
2 quarters
|
|
32
Caterpillar
CAT
$298B
| $809K | 0.15% |
998
+82
| +9% | +$69.5K |
2024 Q3
8 quarters
|
|
33
Merck
MRK
$361B
| $612K | 0.12% |
4,210
+168
| +4% | +$23.2K |
2024 Q3
8 quarters
|
|
34
Deere & Co
DE
$178B
| $609K | 0.12% |
907
-5
| -0.5% | -$3.18K |
2024 Q3
8 quarters
|
|
35
Nucor
NUE
$62.5B
| $532K | 0.1% |
2,275
| – | – |
2024 Q3
8 quarters
|
|
36
Gilead Sciences
GILD
$205B
| $457K | 0.09% |
3,069
+250
| +9% | +$35.1K |
2024 Q3
8 quarters
|
|
37
Pulse Biosciences
PLSE
$3.96B
| $379K | 0.07% |
+7,590
| New | +$320K |
2026 Q3
0 quarters
|
|
|
38
GE Aerospace
GE
$325B
| $314K | 0.06% |
+1,004
| New | +$348K |
2026 Q3
0 quarters
|
|
39
Abbott
ABT
$181B
| $287K | 0.05% |
2,905
| – | – |
2024 Q3
8 quarters
|
|
40
Oracle
ORCL
$423B
| $282K | 0.05% |
2,052
| – | – |
2024 Q3
8 quarters
|
|
41
Visa
V
$767B
| $267K | 0.05% |
+742
| New | +$271K |
2026 Q3
0 quarters
|
|
42
Marriott International
MAR
$104B
| $239K | 0.05% |
+673
| New | +$240K |
2026 Q3
0 quarters
|
|
43
American Electric Power
AEP
$70.4B
| $225K | 0.04% |
+1,895
| New | +$240K |
2026 Q3
0 quarters
|
|
44
Evolus
EOLS
$497M
| $201K | 0.04% |
+25,070
| New | +$188K |
2026 Q3
0 quarters
|
|
45
BioCryst Pharmaceuticals
BCRX
$2.18B
| $198K | 0.04% |
+23,710
| New | +$223K |
2026 Q3
0 quarters
|
|
46
BlackRock MuniHoldings California Quality Fund
MUC
$1.26B
| $105K | 0.02% |
+10,750
| New | +$114K |
2026 Q3
0 quarters
|
|
|
47
Broadcom
AVGO
$1.65T
| – | – |
-622
| Closed | -$235K | – |
|
48
Duke Energy
DUK
$98.2B
| – | – |
-1,748
| Closed | -$221K | – |
|
49
Intel
INTC
$487B
| – | – |
-1,680
| Closed | -$235K | – |
|
Similar funds
A
III
Bender Robert & Associates's Q3 2026 Portfolio in Review
As of Q3 2026, Bender Robert & Associates held 49 positions worth $525M, up 9% from $481M the previous quarter. Its ten largest holdings account for 72% of the portfolio.
Bender Robert & Associates's Q3 2026 filing shows 10 new, 13 increased, 19 reduced and 3 closed positions. Its largest new stake was ASML: 7,214 shares worth $13.1M. The largest sale was Apple, an estimated $5.93M.
By sector, the portfolio is most concentrated in Technology at 51% of assets, up from 49% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Bender Robert & Associates's largest Q3 2026 buy was ASML: 7,214 shares worth $13.1M.
- Bender Robert & Associates added most to GE Vernova in Q3 2026, an estimated $652K increase.
- Bender Robert & Associates's biggest Q3 2026 reduction was Apple, cutting an estimated $5.93M.
- Bender Robert & Associates fully exited Broadcom in Q3 2026, selling an estimated $235K.
- Bender Robert & Associates's ten largest holdings make up 72% of its $525M portfolio in Q3 2026.
- Bender Robert & Associates opened 10 new positions and closed 3 in Q3 2026.
- Bender Robert & Associates's portfolio value rose 9% quarter-over-quarter to $525M.
Based on Bender Robert & Associates's 13F filing for Q3 2026, filed 21 Oct 2026.